Art

J-GLOBAL ID：201902246738919346   Reference number：19A1369318

Low Baseline High-Sensitive C-Reactive Protein is Associated with Coronary Atherosclerosis Regression: Insights from the MILLION Study

ベースライン時の高感度C反応性蛋白質低値は冠動脈硬化症退縮と関連する:MILLION研究からの洞察

Author (6)： Sakata Kenji (Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine) ,  Gamou Tadatsugu (Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine) ,  Tada Hayato (Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine) ,  Hayashi Kenshi (Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine) ,  Ino Hidekazu (Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine) ,  Yamagishi Masakazu (Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine)
Material： Journal of Atherosclerosis and Thrombosis (Web)  (J Atheroscler Thromb (Web))
Volume： 26  Issue： 5  Page： 442-451(J-STAGE)  Publication year： 2019 
JST Material Number： U0153A  ISSN： 1880-3873  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *high sensitivity C-reactive protein ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1369318&from=J-GLOBAL&jstjournalNo=U0153A") }}

Author keywords (4)： High-Sensitivity C-Reactive Protein ,  Amlodipine ,  Atorvastatin ,  Intravascular ultrasound

JST classification (3)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M) ,  Clinical application of drugs acting on lipid metabolism  (GW13050X) ,  Clinical application of vasoactive drugs and hypotensive drugs  (GW07050U)

Substance index (2)： Atorvastatin ,  Amlodipine

Reference (25)：

• 1) Bayturan O, Kapadia S, Nicholls SJ, Tuzcu EM, Shao M, Uno K, Shreevatsa A, Lavoie AJ, Wolski K, Schoenhagen P, Nissen SE, Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol, J Am Coll Cardiol. 2010; 55: 2736-2742
• 2) Ross R, Atherosclerosis-an inflammatory disease, N Engl J Med. 1999; 340: 115-126
• 3) Libby P, Inflammation in atherosclerosis, Arterioscler Thromb Vasc Biol. 2012; 32: 2045-2051
• 4) Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J, C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012; 367: 1310-1320
• 5) Ridker PM, Kastelein JJ, Genest J, Koenig W, C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care, Eur Heart J. 2013; 34: 1258-1261

Terms in the title (5)： ベースライン ,  高感度C反応性蛋白質 ,  冠動脈硬化症 ,  研究 ,  洞察